The images were film-based, and subtle early signs of cancer could have been missed. Today, the same woman undergoes a ...

At the 38th European Association of Nuclear Medicine (EANM) Congress, held from October 4–8 in Barcelona, United Imaging, a ...

Molecular Machines & Industries (MMI) is the leading provider of microscope based micromanipulation solutions for the life sciences, material sciences, and healthcare. We specialize in single cell ...

Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate ...

Molecular machine learning (ML) underpins critical workflows in drug discovery, material science, and catalyst optimization by rapidly predicting molecular interactions and properties. For instance, ...

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "United States Molecular Imaging Market Report by Modality, Application, End Use, States and Company Analysis, 2025-2033" report has been added to ...

Early detection is key to breast cancer survival. But nearly half of all women in the U.S. have dense breast tissue, which can make detecting breast cancer difficult with a mammogram.

Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate ...

For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis (DBT) increases overall and invasive cancer detection, according to a study ...

Nearly half of all women who have had a mammogram to screen for breast cancer have been identified as having dense breasts.